Vanguard Group Inc Biocryst Pharmaceuticals Inc Transaction History

Vanguard Group Inc

$5.57 Trillion
Q4 2024

A detailed history of Vanguard Group Inc transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Vanguard Group Inc holds 21,890,422 shares of BCRX stock, worth $205 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

21,890,422

Previous 20,306,596 7.8%

Holding current value

$205 Million

Previous $154 Million 6.66%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	BUY	$7.03 - $8.43 $11.1 Million - $13.4 Million	1,583,826 Added 7.8%	21,890,422 $165 Million
Q3 2024 Nov 13, 2024	BUY	$6.41 - $8.69 $9.85 Million - $13.4 Million	1,537,103 Added 8.19%	20,306,596 $154 Million
Q2 2024 Aug 13, 2024	BUY	$4.13 - $6.79 $4.51 Million - $7.42 Million	1,092,726 Added 6.18%	18,769,493 $116 Million
Q1 2024 May 10, 2024	SELL	$4.89 - $7.65 $425,200 - $665,190	-86,953 Reduced 0.49%	17,676,767 $89.8 Million
Q4 2023 Feb 14, 2024	BUY	$4.98 - $6.77 $11.8 Million - $16.1 Million	2,371,401 Added 15.41%	17,763,720 $106 Million
Q3 2023 Nov 14, 2023	BUY	$6.71 - $7.92 $2.03 Million - $2.39 Million	302,270 Added 2.0%	15,392,319 $109 Million
Q2 2023 Aug 14, 2023	BUY	$6.96 - $8.81 $1.84 Million - $2.33 Million	263,936 Added 1.78%	15,090,049 $106 Million
Q1 2023 May 15, 2023	BUY	$7.94 - $11.84 $4.94 Million - $7.36 Million	621,718 Added 4.38%	14,826,113 $124 Million
Q4 2022 Feb 10, 2023	BUY	$10.5 - $14.2 $3.84 Million - $5.19 Million	365,783 Added 2.64%	14,204,395 $163 Million
Q3 2022 Nov 14, 2022	BUY	$10.79 - $14.81 $306,856 - $421,181	28,439 Added 0.21%	13,838,612 $174 Million
Q2 2022 Aug 12, 2022	BUY	$7.89 - $17.88 $4.76 Million - $10.8 Million	603,133 Added 4.57%	13,810,173 $146 Million
Q1 2022 May 13, 2022	BUY	$11.56 - $19.76 $43.9 Million - $75 Million	3,794,135 Added 40.31%	13,207,040 $215 Million
Q4 2021 Feb 14, 2022	BUY	$11.18 - $15.46 $400,881 - $554,349	35,857 Added 0.38%	9,412,905 $130 Million
Q3 2021 Nov 12, 2021	BUY	$14.21 - $17.65 $1.03 Million - $1.28 Million	72,505 Added 0.78%	9,377,048 $135 Million
Q2 2021 Aug 13, 2021	BUY	$9.5 - $17.24 $88.4 Million - $160 Million	9,304,543 New	9,304,543 $147 Million

Others Institutions Holding BCRX

# of Institutions

277

Shares Held

167M

Call Options Held

728K

Put Options Held

989K

View Full List

About BIOCRYST PHARMACEUTICALS INC

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.74B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

More about BCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Biocryst Pharmaceuticals Inc Transaction History